Clinical Trials Directory

Trials / Completed

CompletedNCT04901091

Study of the Immediate and Long-term Outcomes of the Disease in Patients With Left Ventricular Aneurysm Complicated and Uncomplicated by Thrombosis After Transmural Myocardial Infarction, According to the Hospital Registry: SIBYL

Study of the Immediate and Long-term Outcomes of the Disease in Patients With Left Ventricular Aneurysm Complicated and Uncomplicated by Thrombosis After Transmural Myocardial Infarction, According to the Hospital Registry

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
National Medical Research Center for Therapy and Preventive Medicine · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

A prospective non-interventional study aimed to evaluate the immediate and long-term outcomes in patients with left ventricular aneurysm after transmural myocardial infarction. A registry of patients with transmural myocardial infarction admitted to the Emergency Department of Cardiology will be created. The registry will include all consecutive hospitalized patients from from January 1, 2021 to December 31, 2021 who meet the inclusion criteria Based on this registry, patients will be divided into groups : patients with left ventricular aneurysm and patients without aneurysm, patients with left ventricular thrombosis and patients without thrombosis. Patients will be contacted in 3 and 12 months. Surviving patients will be invited to appointment for an ECG, echocardiography and survey. The cardiovascular events during this period will be recorded. The factors determining the prognosis of patients and their concomitant diseases, immediate and long-term prognoses, therapeutic measures and drug therapy at the hospital and outpatient stages, and patients ' adherence to therapy will be analyzed.

Conditions

Interventions

TypeNameDescription
OTHERNot ProvidedNot Provided

Timeline

Start date
2021-01-01
Primary completion
2021-12-31
Completion
2022-12-31
First posted
2021-05-25
Last updated
2023-04-28

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04901091. Inclusion in this directory is not an endorsement.